BenQ Medical Technology Cash Flow Conversion Efficiency
BenQ Medical Technology cash flow conversion efficiency. Based on the latest financial reports, BenQ Medical Technology (4116) has a cash flow conversion efficiency ratio of 0.065x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$148.51 Million ≈ $4.68 Million USD) by net assets (NT$2.27 Billion ≈ $71.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of BenQ Medical Technology (2017–2025)
Cash flow conversion efficiency of BenQ Medical Technology from 2017 to 2025. This chart illustrates how BenQ Medical Technology's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BenQ Medical Technology stock quote for real-time trading data and today's change.
BenQ Medical Technology Cash Flow Conversion Ratio Explained
BenQ Medical Technology cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
BenQ Medical Technology Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BenQ Medical Technology ranked by their cash flow conversion efficiency. Also see BenQ Medical Technology stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nebag ag
SW:NBEN
|
0.006x |
|
Verrica Pharmaceuticals Inc
NASDAQ:VRCA
|
-2.154x |
|
Ageagle Aerial Systems Inc
NYSE MKT:UAVS
|
-0.073x |
|
Shinwon
KO:009270
|
0.067x |
|
Durect Corporation
NASDAQ:DRRX
|
-0.447x |
|
Algoltek Inc
TWO:6684
|
0.009x |
|
iLearningEngines, Inc.
NASDAQ:AILE
|
-3.216x |
|
Gold Pacific Co. Ltd
KQ:038530
|
0.000x |
Annual Cash Flow Conversion Efficiency for BenQ Medical Technology (2017–2025)
The table below shows the annual cash flow conversion efficiency of BenQ Medical Technology from 2017 to 2025. Review how much free cash does BenQ Medical Technology generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$2.33 Billion ≈ $73.43 Million |
NT$358.75 Million ≈ $11.30 Million |
0.154x | +59.33% |
| 2024-12-31 | NT$2.30 Billion ≈ $72.47 Million |
NT$222.22 Million ≈ $7.00 Million |
0.097x | -52.38% |
| 2023-12-31 | NT$2.18 Billion ≈ $68.69 Million |
NT$442.35 Million ≈ $13.94 Million |
0.203x | -6.99% |
| 2022-12-31 | NT$1.74 Billion ≈ $54.71 Million |
NT$378.77 Million ≈ $11.93 Million |
0.218x | +97.69% |
| 2021-12-31 | NT$1.10 Billion ≈ $34.65 Million |
NT$121.35 Million ≈ $3.82 Million |
0.110x | -18.63% |
| 2020-12-31 | NT$1.12 Billion ≈ $35.20 Million |
NT$151.48 Million ≈ $4.77 Million |
0.136x | -11.39% |
| 2019-12-31 | NT$1.11 Billion ≈ $34.84 Million |
NT$169.23 Million ≈ $5.33 Million |
0.153x | +32.57% |
| 2018-12-31 | NT$1.09 Billion ≈ $34.42 Million |
NT$126.10 Million ≈ $3.97 Million |
0.115x | +68.85% |
| 2017-12-31 | NT$1.07 Billion ≈ $33.63 Million |
NT$72.97 Million ≈ $2.30 Million |
0.068x | -- |
About BenQ Medical Technology
BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments. The company offers wholesale and retail sales of medical device, medical equipment, pharmaceutical, health food, and the… Read more